Home
Brett R. Hagen, Chief Accounting Officer: Kalaris Therapeutics KLRS Sell · Filed 25/03/27
Trade details
- Type
- Insider sale
- Amount
- $8,135.79
- Shares · price
- 907 sh · $8.97 a share
- Held after
- 1,925 sh
- Trade date
- 25/03/26
- Filed
- 25/03/27
- Days to filing
- 1 days
Sold 32.0% of holdings
- Share of holding sold
- 32.0%
Kalaris Therapeutics trades, last 26 weeks
What else happened in Kalaris Therapeutics around then
Filed or reported within 30 days of the trade day · 25/02/24~25/04/25Brett R. Hagen's recent trades
- Brett R. Hagen
SellKalaris Therapeutics
SellKalaris Therapeutics
KLRS
$12.9K
1,915 sh
$12.9K
Filed 03/23
Traded 03/20
- Brett R. Hagen
Planned saleKalaris Therapeutics
Planned saleKalaris Therapeutics
KLRS
$12.9K
1,915 sh
$12.9K
Filed 03/20
Traded 03/20
- Brett R. Hagen
SellKalaris Therapeutics
SellKalaris Therapeutics
KLRS
$968
96 sh
$968
Filed 25/02/24
Traded 25/02/21
- Brett R. Hagen
Planned saleKalaris Therapeutics
Planned saleKalaris Therapeutics
KLRS
$967
96 sh
$967
Filed 25/02/24
Traded 25/02/21
- Brett R. Hagen
SellKalaris Therapeutics
SellKalaris Therapeutics
KLRS
$302
32 sh
$302
Filed 25/01/27
Traded 25/01/23